Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
60.10
-0.59 (-0.97%)
At close: Apr 8, 2026, 4:00 PM EDT
60.10
0.00 (0.00%)
After-hours: Apr 8, 2026, 4:53 PM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $8.65 billion as of April 8, 2026. Its market cap has decreased by -10.02% in one year.
Market Cap
8.65B
Enterprise Value
7.21B
1-Year Change
-10.02%
Ranking
Category
Stock Price
$60.10
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $8.65B, an increase of 526.80%. That is a compound annual growth rate of 37.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 8.73B | 44.61% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 9.27B |
| Axsome Therapeutics | 8.68B |
| Praxis Precision Medicines | 8.64B |
| Arrowhead Pharmaceuticals | 8.56B |
| Bio-Techne | 8.42B |
| Nuvalent | 8.15B |
| Cytokinetics | 8.00B |
| Krystal Biotech | 7.65B |